Acute hepatitis C virus is a relatively mild infection, and most people are unaware they have become infected; however, HCV becomes chronic in 80 percent of those infected. Currently, 170 million people worldwide are infected with HCV. The standard treatment is a combination therapy of interferon and ribavirin, which is only effective in about 55 percent of patients.
The remaining 45 percent face a threat of the disease progressing to cirrhosis and liver cancer.
33 year old male patient with decompensated liver cirrhosis, ascites, and jaundice as a result of viral hepatitis.